Trastuzumab deruxtecan effectively controlled recurrent ovarian large-cell neuroendocrine carcinoma with low-level HER-2 expression: a case report
Article in Frontiers in Oncology (January 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (January 2024)
Article in Pathology (January 2023)
Article in Frontiers in Oncology (November 2022)